Kuros Biosciences AG

OTCPK:CSBT.F Stock Report

Market Cap: US$843.6m

Kuros Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CSBT.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,220,2328.57%
Institutions6,404,59317%
Individual Insiders9,162,17624.4%
General Public18,785,91050%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.

Top Shareholders

Top 25 shareholders own 50% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.1%
C. Oomen
8,299,433US$186.3m0%no data
4.68%
Hatstone Fund Services Limited
1,757,777US$39.5m0%no data
4.67%
Global Fund Advisors Limited, Asset Management Arm
1,754,946US$39.4m0%98.79%
3.89%
Aldabra B.V
1,462,455US$32.8m0%no data
3.35%
BlackRock, Inc.
1,257,834US$28.2m1,990%no data
2.94%
UBS Asset Management AG
1,104,870US$24.8m0%no data
2.81%
Medical Strategy GmbH, Asset Management Arm
1,056,504US$23.7m0%1.46%
1.94%
Clemens van Blitterswijk
729,410US$16.4m0%no data
1.59%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
599,272US$13.5m0%0.48%
0.48%
ZKB Asset Management
180,399US$4.1m-5.18%0.01%
0.35%
Christopher Fair
133,333US$3.0m0%no data
0.31%
Zürcher Kantonalbank, Investment Arm
116,782US$2.6m4.85%0.02%
0.25%
Valiant Bank AG, Asset Management Arm
95,667US$2.1m46.3%0.22%
0.13%
Equinor Asset Management ASA
48,750US$1.1m0%0.03%
0.11%
Migrosbank Asset Management
41,461US$930.9k0%0.06%
0.11%
BCV Asset Management
40,000US$898.1k0%0.02%
0.059%
NFS Capital AG
22,000US$493.9k0%0.18%
0.058%
State Street Global Advisors, Inc.
21,603US$485.1k115%no data
0.041%
Pictet Asset Management SA
15,360US$344.9k0%no data
0.033%
Swiss Rock Asset Management AG
12,500US$280.7k0%0.03%
0.027%
INTERSELECT NV
10,000US$224.5k0%1.73%
0.022%
Lombard Odier Asset Management (Switzerland) SA
8,219US$184.5k0%no data
0.019%
Union Bancaire Privee, CBI-TDB, Asset Management Arm
6,985US$156.8k0%no data
0.017%
Baloise Asset Management
6,204US$139.3k0%0.01%
0.013%
Vogt Asset Management Trust Reg.
4,775US$107.2k0%0.06%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 13:55
End of Day Share Price 2024/12/11 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kuros Biosciences AG is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laura Pfeifer-RossiBank am Bellevue
Olav ZilianMirabaud Securities Limited
Dylan van HaaftenNIBC Bank N.V.